J&J expands shared lab; New CEO named at Orexo;

 @FierceBiotech: Popular yesterday on FierceBiotech.com : $ALNY licenses away hot PCSK9 prospect in 'small' $205M deal. Article | Follow @FierceBiotech

@JohnCFierce: This is my weird deal of the week: Merck KGaA gets option on MS therapeutic vaccine. Story | Follow @JohnCFierce

@RyanMFierce: Merck Serono risks short money ($5M upfront) in this MS option deal w/ Opexa. Echoes of Celsion's China pact for ThermoDox. | Follow @RyanMFierce

> Johnson & Johnson ($JNJ) is expanding its shared lab in San Diego, providing new opportunities for biotech startups. The move will allow J&J to accommodate 30 companies, after starting with 18. Story

> Nikolaj Sørensen, currently chief commercial officer of Orexo, is being promoted to CEO of the company, and Martin Nicklasson, currently chairman of the board, has been named executive chairman. Sørensen will succeed Anders Lundström, who is stepping down as CEO. Release

> The Indianapolis Business Journal reports that Eli Lilly ($LLY) has a chance to file for approval of up to 5 drugs this year. Report

Pharma News

@FiercePharma: Exanatide (Bydureon and Byetta), now sold by BMS/AZ, helped obese teens lose some weight in small study. More | Follow @FiercePharma

@EricPFierce: Ranbaxy plant problems devastate its share of generic Lipitor market. Report | Follow @EricPFierce

@AlisonBFierce: The FDA approved Sun Pharma's generic version of Johnson & Johnson's cancer drug Doxil to end a months-long shortage. News | Follow @AlisonBFierce

> While BMS shops emerging markets brands, GSK wraps $900M buy in India. Report

> Layoffs, check. Now, on to hiring--and talent's scarce. News

> FDA approves generic Doxil to combat drug shortage. Story

Medical Device News

 @FierceMedDev: Popular yesterday: GE, NFL to pour $50M into concussion imaging tech. Story | Follow @FierceMedDev

 @MarkHFierce: Becton Dickinson's 2013 Q1 numbers impress. More | Follow @MarkHFierce

 @DamianFierce: Take a look at our list of last year's 10 most important FDA approvals in medical devices and diagnostics. Special Report | Follow @DamianFierce

> Edwards rides Sapien sales to big Q4. Story

> New needle free blood Dx targets anemia in India. Item

> Israel's NeuroQuest targets summer start for Alzheimer's blood Dx pivotal trial. Report

Biotech Research News

> New Alzheimer's drug clears amyloid tangles in mice. Item

> Gene discovery could provide relief for deadly staph infections. Report

> New target that stops metastasis could lead to safer cancer therapies. News

> Merck Serono, Feinstein Institute form collaboration to find lupus treatments. Story

Pharma Manufacturing News

> Ranbaxy production glitch devastates its generic Lipitor biz. News

> Aspen to buy Merck API plant in Netherlands to feed expansion. Article

> Ben Venue Bedford plant still missing GMP standards. Story

> FDA nails Novo for missing 850 samples over 2 years. Report

And Finally… Harvard researchers have found out that couch potatoes have significantly lower sperm counts than athletes. Story

Suggested Articles

The discovery that 500 cancers can be slotted into 10 subtypes, each of which is driven by a common set of proteins, could inspire new therapies.

Can an unexpected Sarepta win be good news for Biogen?

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.